Star Lake Bioscience Co., Ltd. logo

Star Lake Bioscience Co., Ltd. (600866)

Market Open
10 Aug, 06:57
SSE SSE
¥
4. 48
+0.05
+1.1287%
¥
10.63B Market Cap
- P/E Ratio
1.52% Div Yield
22.93M Volume
- Eps
¥ 4.43
Previous Close
Add Transaction
Day Range
4.42 4.5
Year Range
4.26 8.55
Want to track 600866 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

600866 trading today higher at ¥4.48, an increase of 1.1287% from yesterday's close, completing a monthly increase of 1.5873% or ¥0.07. Over the past 12 months, 600866 stock lost -35.7245%.
600866 pays dividends to its shareholders, with the most recent payment made on Jul 23, 2026. The next estimated payment will be in In 11 months on Jul 23, 2027 for a total of ¥0.38.
The last earnings report, released on May 13, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Star Lake Bioscience Co., Ltd. has completed 10 stock splits, with the recent split occurring on Nov 28, 2005.
The company's stock is traded on one exchange.

600866 Chart

People also search for

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
¥ 140.8
+0.7369%
Shanghai United Imaging Healthcare Co., Ltd.
¥ 112.74
+0.0355%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
¥ 30.71
+0.8207%
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares
¥ 140
+2.1898%
Beijing Tiantan Biological Products Co., Ltd.
¥ 12.85
+0.5477%

Star Lake Bioscience Co., Ltd. (600866) FAQ

What is the stock price today?

The current price is ¥4.48.

On which exchange is it traded?

Star Lake Bioscience Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 600866.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.52%.

What is its market cap?

As of today, the market cap is 10.63B.

Has Star Lake Bioscience Co., Ltd. ever had a stock split?

Star Lake Bioscience Co., Ltd. had 10 splits and the recent split was on Nov 28, 2005.

Star Lake Bioscience Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Ying Jun EMBA CEO
SSE Exchange
CNE000000H46 ISIN
CN Country
9,012 Employees
23 Jul 2026 Last Dividend
28 Nov 2005 Last Split
10 Apr 1992 IPO Date

Overview

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong, established in 1964, is a Chinese-based company renowned for manufacturing and distributing pharmaceutical raw materials, alongside food and feed additives. Operating under the Star Lake and Yue Bao brand names, it serves a wide range of customers both in China and internationally. The company's product line caters to diverse requirements, from pharmaceutical to food industries, showcasing a robust versatility in its manufacturing capabilities.

Products and Services

The company's product portfolio includes:

  • L-proline: An essential intermediate for synthesizing captopril and enalapril, L-proline also serves as a raw material for amino acid transfusion, highlighting its significance in pharmaceutical manufacturing.
  • Guanosine: Used both as a food additive and a pharmaceutical raw material, guanosine represents a versatile intermediate in the company’s product range.
  • Adefovir dipivoxil tablets: This product aims to combat Hepatitis B virus (HBV) by reducing the activity of HBV DNA polymerase, showcasing the company's commitment to contributing to public health remedies.
  • L-threonine: Primarily used in premixtures and as feed for pigs and poultry, L-threonine underscores the company's role in the agricultural sector.
  • Disodium 5'-ribonucleotide: Utilized for the treatment of conditions such as chronic hepatitis, muscular atrophy, and various eye diseases, marking its importance in therapeutic applications.
  • Disodium 5-inosinate: Targeted for curing leukopenia, thrombocytopenia, chronic and acute hepatitis, this product further diversifies the company’s healthcare product lineup.
  • Inosine: Applicable for the treatment of chronic hepatitis, heart disease, and other conditions, inosine illustrates the company's broad approach to healthcare treatments.
  • Disodium 5'-guanylate: Employed primarily in food processing, including canned and salted meat, ham, and others, enhancing flavor and quality in various food products.
  • Additional Products: The company also produces ribavirin, adenosine, adenine, memantine hydrochloride, arginine, D-ribose, fructose syrup, L-valine, L-lysine, among others, expanding its comprehensive portfolio to address a wider spectrum of market demands.

Contact Information

Address: No. 67, Gongnong North Road, Zhaoqing, China, 526040
Phone: 86 75 8229 1130